PSP
RMD icon

Principal Street Partners’s ResMed RMD Stock Holding History

Principal Street Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,468
Closed -$2.23M – 222
2021
Q1 		$2.23M Buy
11,468
+5,075
+79% +$1.02M 0.29% 66
2020
Q4 		$1.36M Buy
6,393
+291
+5% +$58K 0.42% 62
2020
Q3 		$1.05M Hold
6,102
– – 0.37% 70
2020
Q2 		$1.17M Sell
6,102
-95
-2% -$15.5K 0.44% 63
2020
Q1 		$913K Sell
6,197
-1,141
-16% -$182K 0.38% 59
2019
Q4 		$1.14M Buy
+7,338
New +$1.06M 0.25% 70

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Street Partners's RMD Position: Q2 2021 in Review

Principal Street Partners sold out of ResMed (RMD) in Q2 2021, closing a stake of 11,468 shares — an estimated $2.23M sold.

Principal Street Partners first reported a position in RMD in Q4 2019 and held it in 6 quarters. The position peaked at $2.23M in Q1 2021. 661 funds tracked by Wall St. Rank hold RMD as of Q2 2021.

  • Principal Street Partners reported no remaining ResMed position as of Q2 2021 after selling out during the quarter.
  • Principal Street Partners sold 11,468 ResMed shares in Q2 2021, an estimated $2.23M.
  • Principal Street Partners first reported a position in ResMed in Q4 2019 and held it in 6 quarters.
  • Principal Street Partners's ResMed position peaked at $2.23M in Q1 2021.
  • 661 funds tracked by Wall St. Rank held ResMed as of Q2 2021.

Based on Principal Street Partners's 13F filing for Q2 2021, filed 10 Aug 2021.